7.93 USD
-0.06 (-0.75%)
7.93 USD
0 (0%)
BVS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. BVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- BVS had positive earnings in the past year.
- In the past year BVS had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
- BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 1.11%, BVS is doing good in the industry, outperforming 75.14% of the companies in the same industry.
- With a decent Return On Equity value of 4.71%, BVS is doing good in the industry, outperforming 76.76% of the companies in the same industry.
- BVS's Return On Invested Capital of 6.62% is amongst the best of the industry. BVS outperforms 80.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BVS's Profit Margin of 1.39% is fine compared to the rest of the industry. BVS outperforms 74.05% of its industry peers.
- The Operating Margin of BVS (8.03%) is better than 75.68% of its industry peers.
- In the last couple of years the Operating Margin of BVS has declined.
- BVS has a better Gross Margin (67.76%) than 72.97% of its industry peers.
- BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
- BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- BVS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BVS has more shares outstanding
- BVS has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 1.26, we must say that BVS is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of BVS (1.26) is comparable to the rest of the industry.
- The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
- BVS's Debt to FCF ratio of 6.22 is fine compared to the rest of the industry. BVS outperforms 76.76% of its industry peers.
- BVS has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of BVS (1.93) is worse than 81.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.26 |
ROIC/WACC0.6
WACC10.96%
2.3 Liquidity
- BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BVS (1.74) is worse than 67.57% of its industry peers.
- A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
- BVS has a Quick ratio of 1.14. This is in the lower half of the industry: BVS underperforms 70.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 51.28% over the past year.
- Measured over the past years, BVS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.93% on average per year.
- BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
- Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
- Based on estimates for the next years, BVS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
- Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- BVS is valuated correctly with a Price/Earnings ratio of 13.44.
- Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 91.35% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (27.47), we can say BVS is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 9.88, the valuation of BVS can be described as reasonable.
- Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 95.14% of the companies in the same industry.
- BVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.44 | ||
| Fwd PE | 9.88 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaply inside the industry as 90.81% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, BVS is valued cheaper than 96.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.27 | ||
| EV/EBITDA | 10.23 |
4.3 Compensation for Growth
- BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BVS's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. Dividend
5.1 Amount
- BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
7.93
-0.06 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners74.45%
Inst Owner Change0.02%
Ins Owners2.5%
Ins Owner Change-0.35%
Market Cap656.29M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (92.94%)
Short Float %3.01%
Short Ratio5.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)0%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.44 | ||
| Fwd PE | 9.88 | ||
| P/S | 1.16 | ||
| P/FCF | 12.27 | ||
| P/OCF | 11.71 | ||
| P/B | 3.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.23 |
EPS(TTM)0.59
EY7.44%
EPS(NY)0.8
Fwd EY10.13%
FCF(TTM)0.65
FCFY8.15%
OCF(TTM)0.68
OCFY8.54%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.32
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.26 |
F-Score8
WACC10.96%
ROIC/WACC0.6
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.72%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.44 and the Price/Book (PB) ratio is 3.95.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.